Encoded Libraries for Small Molecule Discovery Icon

Cambridge Healthtech Institute’s 5th Annual

Encoded Libraries for Drug Discovery

Expanding Chemical Space for New Chemical Entities

April 12-13, 2023

 

At Cambridge Healthtech Institute’s 5th Annual Encoded Libraries for Drug Discovery conference, converge with fellow discovery chemists to discuss and stay abreast of one of the industry’s newest drug lead generation strategies: DNA-encoded libraries (DEL). While DEL has proven useful for expanding chemical space and rapidly generating many hits against a given target, there are limitations on the types of targets that can be screened against and moving from the hit to lead step.  

 

Coverage will likely include:

 

  • Case studies and success stories of DEL-origin compounds
  • Increasing the chemical diversity of DEL 
  • Expanding DNA-compatible reactions for chemical building blocks
  • DEL for new target classes such as non-soluble, purified protein targets (e.g. membrane proteins)
  • AI applications and other ways to streamline hit selection and expand chemical space
  • DEL versus other lead generation strategies (FBDD, HTS)
  • New applications of DEL: fragment-based drug discovery and target validation 

 

The deadline for priority consideration is September 23, 2022.

 

All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

 

We hope you can join us for the 5 concurrent day-and-a-half conferences during each half of our 18th Annual Drug Discovery Chemistry event. Registering for this conference lets you also move back and forth among parallel programs to create your own agenda.

 

Opportunities for Participation:

 

 

For more details on the conference, please contact:

Anjani Shah, PhD

Senior Conference Director and Lead Content Director for Drug Discovery Chemistry

Cambridge Healthtech Institute

Phone: (+1) 781-247-6252

Email: ashah@healthtech.com

 

For sponsorship information, please contact:

Kristin Skahan

Senior Business Development Manager

Cambridge Healthtech Institute

Phone: (+1) 781-972-5431

Email: kskahan@healthtech.com